Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FAVXZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,168
Award facts
- Contract value 100% obligated
- $41,168.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $41,168.26 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 5, 2025, with an ultimate completion date of August 6, 2025. The contract covers the delivery of Dupixent 300 mg/2 ml pen (2 ml) for use at the place of performance in Conshohocken, Pennsylvania. This delivery order was issued under a firm fixed-price structure with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly based on its capabilities as a certified woman-owned small business entity.
This delivery order is issued pursuant to DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing delivery orders for specialized pharmaceutical products including injectable medications, oncology treatments, and other prescription items essential to military health operations.
Quick answers
Who was awarded contract SPE2DB25FAVXZ?
SPE2DB25FAVXZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FAVXZ worth?
The government has obligated $41,168 on SPE2DB25FAVXZ.
Is contract SPE2DB25FAVXZ an order under another contract?
Yes. SPE2DB25FAVXZ is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVXZ competed?
The extent of competition for SPE2DB25FAVXZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award